Dyslipidemia Therapeutics Market is expected to be valued at US $ 53.2 Billion by the end of 2033: Fact.MR Study Rockville, June 05, 2023 (GLOBE NEWSWIRE) -- The recent research analysis by Fact.MR on the global market global dyslipidemia therapeutics provides a thorough overview of the industry’s product,...

Heart Health Preventive Care drove Dyslipidemia Therapeutics Market to Over US$ 36 Bn in 2018, finds Fact.MR Rockville, MD, Feb. 07, 2019 (GLOBE NEWSWIRE) -- According to a recently released Fact.MR study, revenues from dyslipidemia therapeutics market surpassed US$ 36 billion in 2018. Low-density...